Explore Viking's innovative GLP-1/GIP & THR-β therapies, with strong Phase 2/3 results, targeting major markets with ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with ...

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...

Biotech firm Synthego files for bankruptcy despite a purchase agreement with Perceptive Advisors and plans for operational ...

Krystal Biotech ( ($KRYS) ) has issued an announcement. On May 16, 2025, Krystal Biotech held its Annual Meeting of Stockholders where key ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...